Loading...
XSTO
SPEC
Market cap20mUSD
Jun 13, Last price  
0.34SEK
1D
-2.84%
1Q
-82.90%
Jan 2017
-80.12%
IPO
-76.41%
Name

SpectraCure AB (publ)

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
9.86
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.17%
Rev. gr., 5y
661.46%
Revenues
20m
+6,042.14%
1,490,125476,195778,500172,912258,953596,0007631,2110539,000318,00019,532,000
Net income
-23m
L+12.54%
-5,732,138-4,345,965-5,884,582-6,372,149-8,696,619-9,610,000-13,685,000-15,407,000-23,341,000-25,326,000-20,441,000-23,004,000
CFO
-22m
L+16.84%
0-604,491-9,714,363-19,596,2366,325,959-8,972,000-10,055,000-9,404,000-18,603,000-22,962,000-18,680,000-21,826,000

Profile

SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
URL
https://spectracure.com/
IPO date
Jul 01, 2015
Employees
13
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
19,532
6,042.14%
318
-41.00%
539
 
Cost of revenue
9,766
9,541
8,575
Unusual Expense (Income)
NOPBT
9,766
(9,223)
(8,036)
NOPBT Margin
50.00%
Operating Taxes
7
(21)
(53)
Tax Rate
0.07%
NOPAT
9,759
(9,202)
(7,983)
Net income
(23,004)
12.54%
(20,441)
-19.29%
(25,326)
8.50%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,542
2,320
2,430
Long-term debt
7,748
11,114
2,970
Deferred revenue
Other long-term liabilities
Net debt
(7,984)
(44,211)
(89,010)
Cash flow
Cash from operating activities
(21,826)
(18,680)
(22,962)
CAPEX
(130)
(15,767)
(10,117)
Cash from investing activities
(15,279)
(15,562)
(11,347)
Cash from financing activities
(1,572)
(1,987)
(2,203)
FCF
11,309
(12,198)
(5,762)
Balance
Cash
18,274
56,951
93,180
Long term investments
694
1,230
Excess cash
17,297
57,629
94,383
Stockholders' equity
(151,158)
(128,154)
(107,715)
Invested Capital
263,159
264,730
260,714
ROIC
3.70%
ROCE
8.72%
EV
Common stock shares outstanding
97,132
97,132
97,132
Price
2.55
-33.94%
3.86
-23.11%
5.02
-14.63%
Market cap
247,686
-33.94%
374,928
-23.11%
487,601
-14.63%
EV
239,702
330,717
398,591
EBITDA
9,766
(6,561)
(5,104)
EV/EBITDA
24.54
Interest
522
182
Interest/NOPBT